Intensity Therapeutics, Inc.
INTS
$4.04
$0.020.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.01M | -2.43M | -3.05M | -2.67M | -2.54M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 394.00K | 394.00K | 457.00K | 477.00K | 651.00K |
| Change in Net Operating Assets | 273.00K | 214.00K | 193.00K | -193.00K | -570.00K |
| Cash from Operations | -2.34M | -1.83M | -2.40M | -2.39M | -2.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.68M | 157.00K | 7.82M | 7.54M | 4.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.00K | -7.00K | -565.00K | -301.00K | -933.00K |
| Cash from Financing | 1.62M | 150.00K | 7.26M | 7.24M | 3.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -716.00K | -1.68M | 4.85M | 4.85M | 1.29M |